Evidence map›Paper›PMID 30024881›Full record

ArticlePLoS genetics2018

Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier.

Nicholas A Willis, Arvind Panday, Erin E Duffey, Ralph Scully

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. International journal of oncology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. The Altered Functions of Shelterin Components in ALT Cells.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Characterization of Unidirectional Replication Forks in the Mouse Genome.International journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. REV7 directs DNA repair pathway choice.Trends in cell biology · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Replication-Coupled DNA Repair.Molecular cell · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicholas A WillisDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0003-2091-5462
Arvind PandayDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.
Erin E DuffeyDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.
Ralph ScullyDepartment of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-5064-0175
Beth Israel Deaconess Medical Center · US

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI MYLES A BROWN · 2013 to 2026
$30.1M
ANALYSIS OF BRCA1 RECOMBINATION FUNCTIONSR01CA095175 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2002 to 2021
$4.9M
FANCM in repair of stalled replication forksR01CA217991 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2017 to 2021
$2.0M
Replication fork collapse in mammalian cellsR21ES027776 · NIEHS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCULLY, RALPH · 2017 to 2018
$476k
NCI NIH HHS P50 CA168504NCI NIH HHS R01 CA095175NCI NIH HHS R01 CA217991NIEHS NIH HHS R21 ES027776
6 · The paper itself

Abstract

Classical non-homologous end joining (C-NHEJ) and homologous recombination (HR) compete to repair mammalian chromosomal double strand breaks (DSBs). However, C-NHEJ has no impact on HR induced by DNA nicking enzymes. In this case, the replication fork is thought to convert the DNA nick into a one-ended DSB, which lacks a readily available partner for C-NHEJ. Whether C-NHEJ competes with HR at a non-enzymatic mammalian replication fork barrier (RFB) remains unknown. We previously showed that conservative "short tract" gene conversion (STGC) induced by a chromosomal Tus/Ter RFB is a product of bidirectional replication fork stalling. This finding raises the possibility that Tus/Ter-induced STGC proceeds via a two-ended DSB intermediate. If so, Tus/Ter-induced STGC might be subject to competition by C-NHEJ. However, in contrast to the DSB response, where genetic ablation of C-NHEJ stimulates HR, we report here that Tus/Ter-induced HR is unaffected by deletion of either of two C-NHEJ genes, Xrcc4 or Ku70. These results show that Tus/Ter-induced HR does not entail the formation of a two-ended DSB to which C-NHEJ has competitive access. We found no evidence that the alternative end-joining factor, DNA polymerase θ, competes with Tus/Ter-induced HR. We used chromatin-immunoprecipitation to compare Rad51 recruitment to a Tus/Ter RFB and to a neighboring site-specific DSB. Rad51 accumulation at Tus/Ter was more intense and more sustained than at a DSB. In contrast to the DSB response, Rad51 accumulation at Tus/Ter was restricted to within a few hundred base pairs of the RFB. Taken together, these findings suggest that the major DNA structures that bind Rad51 at a Tus/Ter RFB are not conventional DSBs. We propose that Rad51 acts as an "early responder" at stalled forks, binding single stranded daughter strand gaps on the arrested lagging strand, and that Rad51-mediated fork remodeling generates HR intermediates that are incapable of Ku binding and therefore invisible to the C-NHEJ machinery.

Indexed as

AnimalsCell LineDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA-Directed DNA PolymeraseDNA End-Joining RepairDNA Polymerase thetaDNA ReplicationHomologous RecombinationKu AutoantigenMiceMice, TransgenicMouse Embryonic Stem CellsMutationRad51 RecombinaseDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA Polymerase thetaKu AutoantigenRad51 protein, mouseRad51 RecombinaseXRCC4 protein, mouseXrcc6 protein, mouse

Identifiers

PMID30024881
PMCPMC6067765
OpenAlexW2884210846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.